Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
145.3 USD | -1.21% | -1.79% | +22.98% |
May. 27 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection | MT |
May. 15 | UBS Raises Crane's Price Target to $152 From $120, Maintains Neutral Rating | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- CR Stock
- Revisions Crane Company